This opportunity is no longer accepting applications.
grant PAR-22-222

Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

This grant opportunity is aimed at supporting the continued development of multipurpose prevention technologies (MPTs) that are innovative and on-demand, targeting the prevention of HIV, sexually transmitted infections (STIs), and pregnancy. It focuses on methods that are either systemic or non-systemic and can involve hormonal or non-hormonal approaches. The grant supports research for both c…

The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection …

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases

Dates

Opportunity Released: August 4, 2022

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.